Joseph Eid, M.D.

Joseph Eid, M.D.

Executive Vice President, Research & Development, Chief Medical Officer (as of November 11, 2024)atGeron· In proxies 2024–2025

Pay in FY2025Geron stock -62.7% the same year

Joseph Eid, M.D. was paid $1.0M in FY2025 (Dec). Geron stock fell 62.7% that year.

Pay$100 in the stock at the end of FY24 → $37
Pay is from the Summary Compensation Table of each Geron proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. GeronPublic company · 2 yr
    • Executive Vice President, Research & Development, Chief Medical Officer (as of November 11, 2024)2024 – Present · 2 yrStock in role -58%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?